Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities

Since nivolumab significantly prolongs survival in patients with metastatic melanoma, the number of patients administered nivolumab is increasing, but only 30–40% of patients who received nivolumab monotherapy experienced objective tumor regression. Therefore, enhancing its anti-tumor immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Furudate, Sadanori, Fujimura, Taku, Kambayashi, Yumi, Hidaka, Takanori, Hashimoto, Akira, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118831/
https://www.ncbi.nlm.nih.gov/pubmed/27920696
http://dx.doi.org/10.1159/000450974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118831/
https://www.ncbi.nlm.nih.gov/pubmed/27920696
http://dx.doi.org/10.1159/000450974

Ejemplares similares